These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8245810)

  • 1. Follow-up of abnormal Papanicolaou smears among women of different races.
    Carey P; Gjerdingen DK
    J Fam Pract; 1993 Dec; 37(6):583-7. PubMed ID: 8245810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
    Benard VB; Lee NC; Piper M; Richardson L
    Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in cervical cancer screening and follow-up for black and white women in the United States.
    Ford S; Tarraf W; Williams KP; Roman LA; Leach R
    Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
    Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
    Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papanicolaou screening in an urgent care setting.
    Dunn TS; Jazbec A; Awad R; Batal H
    Am J Obstet Gynecol; 2005 Apr; 192(4):1084-6. PubMed ID: 15846184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the mildly abnormal Pap smear: a conservative approach.
    Brown MS; Phillips GL
    Gynecol Oncol; 1985 Oct; 22(2):149-53. PubMed ID: 2996992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adequacy of management of women with CIN 2 and CIN 3 Pap smear abnormalities.
    Towler BP; Irwig LM; Shelley JM
    Med J Aust; 1993 Oct; 159(8):523, 526-8. PubMed ID: 8412951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
    Liao SY; Stanbridge EJ
    Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.
    Marcus AC; Crane LA; Kaplan CP; Reading AE; Savage E; Gunning J; Bernstein G; Berek JS
    Med Care; 1992 Mar; 30(3):216-30. PubMed ID: 1538610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.
    Lavin C; Goodman E; Perlman S; Kelly LS; Emans SJ
    J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):141-5. PubMed ID: 9288658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of adequate follow-up of an abnormal Papanicolaou result among Jamaican women in Portland, Jamaica.
    Jeong SJ; Saroha E; Knight J; Roofe M; Jolly PE
    Cancer Epidemiol; 2011 Apr; 35(2):211-6. PubMed ID: 20688592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
    Bansal M; Zhao C
    J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
    Melnikow J; Chan BK; Stewart GK
    Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-income minority women at risk for cervical cancer: a process to improve adherence to follow-up recommendations.
    Cardin VA; Grimes RM; Jiang ZD; Pomeroy N; Harrell L; Cano P
    Public Health Rep; 2001; 116(6):608-16. PubMed ID: 12196621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colposcopy Requirement of Papanicolaou Smear after Atypical Squamous Cells of Undetermined Significance (ASC-US) by Follow-up Protocol in an Urban Gynaecology Clinic, a Retrospective Study in Thailand.
    Perksanusak T; Sananpanichkul P; Chirdchim W; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2015; 16(12):4977-80. PubMed ID: 26163625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Papanicolaou smear return in a hospital-based adolescent and young adult clinic.
    Kahn JA; Goodman E; Huang B; Slap GB; Emans SJ
    Obstet Gynecol; 2003 Mar; 101(3):490-9. PubMed ID: 12636952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal Papanicolaou smears and colposcopic follow-up among American Indian and Alaska Native women in the Pacific northwest.
    Gilbert TJ; Sugarman JR; Cobb N
    J Am Board Fam Pract; 1995; 8(3):183-8. PubMed ID: 7618496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inadequate follow-up for abnormal Pap smears in an urban population.
    Peterson NB; Han J; Freund KM
    J Natl Med Assoc; 2003 Sep; 95(9):825-32. PubMed ID: 14527050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital.
    Lertcharernrit J; Sananpanichkul P; Suknikhom W; Bhamarapravatana K; Suwannarurk K; Leaungsomnapa Y
    Asian Pac J Cancer Prev; 2016; 17(8):4163-7. PubMed ID: 27644678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology.
    Mayeaux EJ; Harper MB; Abreo F; Pope JB; Phillips GS
    J Fam Pract; 1995 Jan; 40(1):57-62. PubMed ID: 7807039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.